FDA Investigator: Mark J. Seaton
- Mark J. Seaton first started conducting FDA inspections in 2000, with the last inspection in 2024. Over that time, Mark J. Seaton has conducted 85 inspections at 80 companies across 78 sites.
Get Mark Seaton's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Joinn Laboratories Co. Ltd., Beijing | 2024
Out-of-stock
Mark J. Seaton
Human Drugs Form 483
FDA 483 Suzhou Xishan Zhongke Drug R&D, Co. Ltd., Suzhou | 2024
Out-of-stock
Mark J. Seaton
Human Drugs Form 483
FDA 483 BASI Gaithersburg, LLC, Gaithersburg | 2024
Out-of-stock
Mark J. Seaton
Human Drugs Form 483
FDA 483 Alturas Analytics, Inc, Moscow | 2020
Out-of-stock
Mark J. Seaton
Human Drug Form 483
FDA 483 Lovelace Biomedical Research Institute, Albuquerque | 2020
Out-of-stock
Mark J. Seaton
Human Drug Form 483
FDA 483 Vimta Labs Ltd., Hyderabad | 2019
Out-of-stock
Mark J. Seaton
Human Drug Form 483
FDA 483 Altasciences Preclinical Seattle, LLC, Everett | 2019
Out-of-stock
Mark J. Seaton
Human Drug Form 483
FDA 483 Level Biotechnology Inc, Tiapei | 2019
Out-of-stock
Mark J. Seaton
Human Drug Form 483
FDA 483 JOINN Laboratories (Suzhou), Taicang | 2019
Out-of-stock
Mark J. Seaton
Human Drug Form 483
FDA 483 Wuxi Apptec Suzhou Co.,Ltd, Suzhou | 2019
Out-of-stock
Mark J. Seaton
Human Drug Form 483
FDA 483 Memorial Sloan-Kettering Cancer Center, New York | 2018
Out-of-stock
Mark J. Seaton
Human Drug Form 483
FDA 483 Experimur, Llc, Chicago | 2018
Out-of-stock
Mark J. Seaton
Human Drug Form 483
FDA 483 Charles River Mattawan, Mattawan | 2018
Out-of-stock
Mark J. Seaton
Human Drug Form 483
FDA 483 National Shanghai Center for New Drug Safety Evaluation Ctr, Shanghai | 2018
Out-of-stock
Mark J. Seaton
Human Drug Form 483
FDA 483 Yunnan Institute of Medicine, Kunming | 2018
Out-of-stock
Mark J. Seaton
Human Drug Form 483
FDA 483 Aurigene Discovery Technologies Ltd., Hyderabad | 2018
Out-of-stock
Mark J. Seaton
Human Drug Form 483
FDA 483 Oeyama-Moto-Medical Group Foundation, LLC, West Covina | 2017
Out-of-stock
Mark J. Seaton
Human Drug Form 483
FDA 483 Toxikon Corp., Bedford | 2017
Out-of-stock
Mark J. Seaton
Human Drug Form 483
FDA 483 National Beijing Center For Drug Safety Evaluation And Resea, Beijing | 2017
Out-of-stock
Mark J. Seaton
Human Drug Form 483
FDA 483 West China-Frontier Pharma Tech Co., Ltd., Sichuan | 2017
Out-of-stock
Mark J. Seaton
Human Drug Form 483
FDA 483 Bioneeds India Private Limited, Bangalore Rural District | 2017
Out-of-stock
Mark J. Seaton
Human Drug Form 483
FDA 483 National Microbiology Laboratory, Winnipeg | 2016
Out-of-stock
Mark J. Seaton
Human Drug Form 483
FDA 483 Centre for Drug Safety Evaluation and Research, Shanghai | 2016
Out-of-stock
Mark J. Seaton
Human Drug Form 483
FDA 483 JOINN Laboratories (Suzhou), Taicang | 2016
Out-of-stock
Mark J. Seaton
Human Drug Form 483
FDA 483 GlaxoSmithKline LLC, King of Prussia | 2016
Out-of-stock
Mark J. Seaton
Human Drug Form 483
FDA 483 Dr. Richard Greil, Salzburg | 2010
Out-of-stock
Mark J. Seaton
Human Drug Form 483
FDA 483 Absorption Systems L.P., Exton | 2002
Out-of-stock
Mark J. Seaton
Human Drug Form 483
FDA 483 Kremer Eye Associates, King Of Prussia | 2002
Out-of-stock
Mark J. Seaton
Medical Devices & Rad Health Form 483
FDA 483 eResearch Technology, Philadelphia | 2002
Out-of-stock
Mark J. Seaton
Human Drug Form 483
FDA 483 Garino, Jonathon M.D., Philadelphia | 2002
Out-of-stock
Mark J. Seaton
Medical Devices & Rad Health Form 483
Co-Investigators (44)
- Deborah A. Greco, FDA Investigator
- Zhou Chen, FDA Investigator
- Gabrielle J. Swain, FDA Investigator
- Sunitha K. Rajaram, FDA Investigator
- Lynda L. Lanning, FDA Investigator
- Angela Shepas, FDA Investigator
- Jonathan R. Campos, FDA Investigator
- Theressa B. Smith, FDA Investigator
- Erin M. McDowell, FDA Investigator
- Janete F. Guardia, FDA Investigator
- Hugh M. McClure, FDA Investigator
- Geoffrey K. Kilili, FDA Investigator
- Marcia A. Worley, FDA Investigator
- Julian C. Hanson, FDA Investigator
- Byungja E. Marciante, FDA Investigator
- Charles R. Bonapace, FDA Investigator
- Marijo B. Kambere, FDA Investigator
- Debra L. Boyd Seale, FDA Investigator
- Boyd Seale, Debra L, FDA Investigator
- Joanne M. Schlossin, FDA Investigator
- Nutan Mytle, FDA Investigator
- Sabine Francke, FDA Investigator
- Nicole C. Victoria, FDA Investigator
- Stephanie C. Mangigian, FDA Investigator
- Kelly N. Kerr, FDA Investigator
- Corey K. Reno, FDA Investigator
- Yiyue Zhang, FDA Investigator
- Jennifer C. Adams, FDA Investigator
- Betsy C. Galliher, FDA Investigator
- Johann M. Fitch, FDA Investigator
- Eias A. Zahalka, FDA Investigator
- Matthew C. Watson, FDA Investigator
- Carmen Y. Fisher, FDA Investigator
- Dawn C. Olenjack, FDA Investigator
- Marcelo O. Mangalindan, FDA Investigator
- Ching-Jey G. Chang, FDA Investigator
- Tahseen Mirza, FDA Investigator
- Gayle S. Lawson, FDA Investigator
- Debra J. Bennett, FDA Investigator
- Joseph L. Despins, FDA Investigator
- Mike M. Rashti, FDA Investigator
- Vlada Matusovsky, FDA Investigator
- Calvin W. Edwards, FDA Investigator
- Gerald W. Kopp, FDA Investigator